 | Up a level |
Journal Article
Christoph, D. C. C., Rizzo, F., Kambartel, K-O., Winke, S., Panse, J., Abdulla, D. S., Scheffler, M., Azeh, I. T., Hoiczyk, M., Turki, A. and Metzenmacher, M. (2020). Docetaxel/nindetanib as efficient treatment option after failure of immune checkpoint inhibition: Real-world evidence. Ann. Oncol., 31. S. S876 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Riedel, R., Kron, A., Michels, S., Fassunke, J., Scheffler, M., Fischer, R., Nogova, L., Abdulla, D., Heydt, C., Ueckeroth, F., Pauli, B., Serke, M., Krueger, S. 
ORCID: 0000-0002-1658-5993, Grohe, C., Sebastian, M., Koschel, D., Kambartel, K-O., Zander, T., Buettner, R. and Wolf, J.
(2017).
Impact of next generation TKI and co-occurring mutations in ALK-positive NSCLC patients: Results of the Network Genomic Medicine.
Ann. Oncol., 28.
OXFORD:
OXFORD UNIV PRESS.
ISSN 1569-8041